Stay updated on Nivolumab vs Temozolomide in GBM Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.

Latest updates to the Nivolumab vs Temozolomide in GBM Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Padova, Italy, 35128 and removed Padua, Italy, 35128 from the locations list.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check63 days agoChange DetectedMinor revision updates were applied: v3.4.2 added and v3.4.1 removed, with no user-facing content or functionality changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0 in the metadata. This is a minor versioning update and does not alter study content or functionality.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page now shows a glossary and QC-related metadata (Last Update Submitted that Met QC Criteria) along with No FEAR Act Data and Revision: v3.4.0. The older QC field capitalization (Last Update Submitted that met QC Criteria), the No FEAR Act data, and Revision: v3.3.4 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Temozolomide in GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Temozolomide in GBM Clinical Trial page.